Rural Women Rise: Belagavi GFGC places 311 students in July, sends off 60 to MNCs in grand ceremony
Belagavi: Government First Grade College (GFGC) for Women, Belagavi, celebrated a major milestone on Monday as it sent off 60 of its students to begin their corporate careers with renowned firms like Tata Electronics, Foxconn, Tata Motors, and Honda.
The event capped a record-breaking placement season that saw 311 out of 480 shortlisted candidates secure job offers in July alone.
Over the past three years, the college hosted at least four job melas annually, placing more than 730 women in multinational corporations, effectively rewriting the narrative for employability in rural Karnataka. Asif Sait, MLA, the chief guest, described the initiative as a landmark moment in women's empowerment, applauding the college for equipping rural daughters with corporate skills.
Dr NR Patil, principal of GFGC, recalled that years ago, only a few of their eligible candidates found jobs. Today, the college's placement cell saw about 50–60% placement rates, with salary packages between INR 2 LPA and INR 3 LPA—meaning this year's success far outpaced the past performance. Placement coordinator Prof Shamshuddin M Nadaf praised the students' resilience. Each placement is a chapter in perseverance.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
No annual fees for life
UnionBank Credit Card
Apply Now
Undo
The faculty coordinated nearly 24/7 to align the curriculum with industry tests and expectations.
Senior professor Ramesh Mangalekar, who led corporate outreach, shared that the college forged new partnerships in Bengaluru this year, opening paths beyond traditional engineering roles. Students on the front line appeared proud and composed. Swathi Patil, headed to Tata Electronics, declared, "I am the first in my family to leave for Bengaluru.
This college made it possible." Meanwhile, Nusrat Banu, joining Foxconn, added, "My village never imagined a daughter in a city office.
Now it has two — me and Swathi."
Parent volunteers reported an emotional send-off. "Why did we think a govt college meant only degrees?" asked Ramesh Patil, father of a student. "This college gave our daughter a job." The event included a cultural tribute and a pledge by students to uphold ethical leadership in the corporate sector. As the ceremony ended beneath the newly installed college logo, there was a resounding conviction: this isn't just a placement drive — it's a movement.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Economic Times
39 minutes ago
- Economic Times
Have money to deploy today? Put it in pharma funds, says Sandeep Tandon
Sandeep Tandon, CIO, Quant Mutual Fund, expresses strong confidence in India's decoupling process, highlighting Asia-centric emerging markets' advantageous position over developed economies, evidenced by currency movements. He identifies the pharmaceutical sector as a prime beneficiary in the current economic climate. Tandon advocates for investing in pharma funds, deeming it a highly promising and straightforward investment strategy. ADVERTISEMENT I just want to pick up on the US indicators that you say could be headed for a deeper correction. In that sense, do you think that in the interim, India is decoupled right now or if they fall, will we fall too? Sandeep Tandon: A few months back also, we talked about the decoupling process beginning. In fact, in March we wrote about India decoupling. I will not say up to a large extent, but up to a small extent, the decoupling process has begun. If anything starts, it is a few years and a few quarters' process, and not going to happen overnight. So, purely on our macro understanding and our behaviour thesis, what we have built in last many years, we are confident that India decoupling process has already begun and not only India, also the emerging market, particularly Asia-centric emerging market is in a far better situation than the developed economies or the developed market and that trend is quite visible in the currency movement also. The whole world in January had written off emerging markets and talked about how the US will go and exactly the reverse happened. I am not saying you should take a contrarian call, but that was the thought process. People thought that Asian market currencies or the emerging market currencies would collapse significantly. Yes, they corrected and if you really ask me, either we have already seen the worst of rupee or we might be seeing very soon, but we are in the fag end of that also. In fact, from a longer-term perspective, the probability that 2025 will be remembered as a long-term top for the USD-INR and the Indian rupee should appreciate over the next five to six years and that is the clear message. If I have to do a reverse calculation and try to interpret it, if the rupee is going to get stronger over a period of five-six years, then obviously it is a clear indication the Indian market also should be doing very well. I want to address some sectors as well. You have a great understanding about the pharma sector. For now, they are exempt from tariffs. But there is all that noise that eventually it is going to be 250% tariffs. What is the practicality of it and for Indian investors, do you now make that disconnect and look at India-focused pharma companies as opposed to the ones which manufacture for the US? Sandeep Tandon: Let us sit down and analyse it all rationally and I am always surprised to see even the best of the analysts get carried away in this narrative getting built about that 250%. Let us understand the US compression. If you recollect, Trump has been threatening for a while, but if you really sit down and analyse, he has been targeting innovators, not generics. The point which he is trying to make is a lot of companies, which are US-centric but manufacture their product in Europe and have huge 50% to 80% or 90% margin when selling in the US. They understand there is a very large margin they are making and that is something they are talking about. A lot of people read it as, at least from the R&D perspective, the budget will go down. So, that is a secondary impact or tertiary impact that can happen. But their focus is on innovators and this time also, he was not able to do anything. Despite making noise, ultimately he has a written letter to bring down the prices. Now, let us understand the larger this is. Does the US have any other source of buying generics or pharmaceuticals? India is the biggest supplier of generics and if innovators are penalised for whatever reason, money or people will shift towards generics and Indian generics are 70% to 90% cheaper as compared to comparative formulation in the US itself. ADVERTISEMENT So, the US or Mr Trump does not have too many options. See, you can defer buying a car for two years. You can defer buying garments or clothes for, let us say for six months or eight months, but you cannot defer buying medicine even for next two hours. That is the compulsion he has. So, we have to understand what is the objective? Yes, he is making noise. But he does not have a choice. If you want to source somewhere and set up manufacturing in the US, it takes three to five years to build a capacity and even then the US FD approval nowadays takes around 12 to 15 months, even 18 months. A lot of plants are still waiting for US approval. Within the US they are not able to devote time, their bandwidth is also limited. So, I do not think anything would happen in the pharma space in a hurry and Indian generics are in a very comfortable position and some of the companies like Lupin have manufacturing facilities in the US. Aurobindo is one of the large players and has two manufacturing facilities. They have recently acquired a third one. So, we have to identify all the generic companies, all the pharma companies that have bases in the US or other they are based in the US, that will give them comfort psychologically if something can drastically change and they can easily export or manufacture there. If you ask me, one single thesis in the current context is the beneficiary in absolute terms and relative terms is pharma. If you ask me where I should put my money if I have to deploy today, then I say put money in pharma funds. This is absolutely no-brainer trade. (You can now subscribe to our ETMarkets WhatsApp channel)
Hans India
an hour ago
- Hans India
Celebrate the festival of Rakhi with the Raksha Bandhan Store on Amazon.in
announced the launch of a special Raksha Bandhan Store with a curated selection of must-haves. Customers can choose from a wide variety of products including rakhis, traditional sweets, fashion, electronics and festive deals to prepare for and celebrate Raksha Bandhan. To help customers share the gift of convenience and choice, Amazon Pay is offering personalised e-Gift cards that allow customers to upload their photos or artwork, making celebrations more meaningful. The enhanced gifting experience includes new physical options like elegant envelopes, premium boxes, and designer greeting cards. For eco-conscious customers, Amazon has introduced seeded paper gift cards that can be planted after use. The digital offering extends to an expanded collection of animated Raksha Bandhan e-Gift cards. "Digital gifting in India has evolved beyond convenience. At Amazon Pay, we're focused on creating emotionally resonant experiences that blend technology with personal connection. Our new features reflect our commitment to making every gifting moment meaningful and personal," said Neha Gupta Mahatme, Director – Stored Value and Gifting, Amazon Pay. Customers across the country have enjoyed sharing Gift Cards with over a billion sold since they were first launched in 2014 on With an average value of INR 3,500, these cards are widely used by customers to buy products across fashion, electronics, and home categories. Customers can also access gift cards from over 300 premium brands spanning jewelry, grocery, entertainment, and travel, all available through with instant digital delivery. These cards can be redeemed on their respective platforms or used to shop from over 10 crore products on Here are some special Raksha Bandhan deals to check out: OnePlus 13R: OnePlus 13R comes with features such as Snapdragon 8 Gen 3 processor, 6000mAh battery, and Sony LYT-700 50MP main camera for exceptional performance. This smartphone is available at ₹ 39,999 boAt Rockerz 550: Experience up to 20 hours of immersive audio with powerful 50mm drivers and plush over-ear cushions, designed for all-day comfort. Additionally, enjoy seamless Bluetooth v5.0 connectivity and physical noise isolation for uninterrupted listening. These earbuds are available for ₹1,599 Noise Pulse Go Buzz Smart Watch: Stay connected and on top of your health with Noise Pulse Go smartwatch that comes with a vibrant 1.69" TFT display, Bluetooth calling, and the Noise Health Suite. Enjoy fast connectivity with Tru Sync and boost daily productivity with smart reminders and utility features, all from your wrist. Get this smartwatch for ₹1,099 Noise Diva Smartwatch with Diamond Cut dial: This is a multi-strapped smart watch with a diamond cut dial. It has a 1.1' AMOLED display with a four-day long battery life It has Bluetooth calling and health features and additional features include calculator, reminders and weather updates. NoiseFit Focus App can be used to track. It is priced at ₹2,799 Bella Vita Luxury Perfume Gift Set for Women: Contains 4 bottles of 20ml in the scents Date Woman, Glam, Rose, and Senorita. The perfume bottles are miniature, and travel sized for ease and convenience. The scents are diverse and long lasting. It is priced at ₹499 Eat Better Co - Bandhan - 8-Item Rakhi Gift Hamper For Brother: Festive the Raksha Bandhan with the Eat Better Co Bandhan Gift Hamper of high-quality Rakhi, nutritious laddoos, chocolate-covered almonds, and more. A carefully designed festive box that combines tradition with healthful delights. Available only at ₹349 Phool Rakhi Premium Gift Box for Brother: Phool Rakhi Gift Box with 15 unique items including a plantable Rakhi, dry fruits, mouth freshener, grooming kit, and tic-tac-toe game, perfect for a fun and eco-friendly Raksha Bandhan. Get this at ₹675 Cadbury Celebrations Rich Dry Fruit Collection Chocolate Gift pack, 177 g: Cadbury Celebrations Rich Dry Fruit Chocolate Gift Box (177 g) offers a delightful mix of creamy milk chocolate with crunchy almonds, cashews, and sweet raisins an indulgent treat ideal for festive moments and heartfelt gifting. Priced at ₹451 Haldiram's Mithas Besan Ladoo - Dry Fruit: These Haldiram's Besan Ladoo (400g) are made with quality ingredients, rich in carbohydrates and proteins, with no added preservatives. A traditional Indian sweet that's soft, pure, and perfect for every festive or gifting occasion. Get this for ₹185 Philips India's No.1 Men's Trimmer: This is a 13-in-1 trimmer which offers precise grooming for face, body and hair with patented Twin Trim Blades and smart Beard Sense Technology. It has 120 mins runtime, 5-min quick charge, self-sharpening waterproof blades with a 2+1 year worldwide warranty. Available for ₹3,496
The Hindu
3 hours ago
- The Hindu
Rupee rises 3 paise to close at 87.69 against U.S. dollar
The rupee consolidated in a narrow range and settled for the day higher by just 3 paise at 87.69 (provisional) against the U.S. dollar on Thursday (August 7, 2025), after U.S. President Donald Trump slapped an additional 25% duty — doubling it to 50% — on Indian goods, denting market sentiments. Forex traders said weak crude oil prices and a decline in the U.S. Dollar index supported the rupee. However, muted domestic markets and foreign fund outflows capped sharp gains. Moreover, Mr. Trump's aggressive move, which kicks in 21 days, threatens to raise total duties on select Indian exports to as high as 50% — making them among the most heavily taxed U.S. imports globally, further dented market sentiments. At the interbank foreign exchange, the domestic unit opened at 87.69 and moved in a range of 87.67-87.77 during the day before settling at 87.69 (provisional), rising 3 paise from its previous close. On Wednesday (August 6, 2025), the rupee rebounded from a record low level and closed 16 paise higher at 87.72 against the U.S. dollar. Mr. Trump's tariffs on Indian exports are likely to hit sectors such as textiles, marine and leather exports hard and were slammed by India as "unfair, unjustified and unreasonable". With this action singling out New Delhi for the Russian oil imports, India will attract the highest US tariff of 50% along with Brazil. The United States has imposed this additional tariff or penalty for Russian imports only on India, while other buyers such as China and Turkey have so far escaped such harsh measures. The 30% tariff on China and 15% on Turkey is lower than India's 50%. "We expect the rupee to slide as the trade tariff deal continues to linger with U.S. President Donald Trump doubling tariff on India to 50%, denting market sentiments. A weak tone in the domestic equities and selling by foreign investors may also pressurise the rupee. "However, weakness in the U.S. dollar and falling global oil prices may support the rupee at lower levels. USD-INR spot price is expected to trade in a range of 87.50 to 88," Anuj Choudhary – Research Analyst, commodities and currencies, Mirae Asset Sharekhan. Meanwhile, the Reserve Bank of India (RBI) on Wednesday (August 6, 2025) decided to keep the policy rate unchanged at 5.5% and retained the neutral stance, amid concerns over tariff uncertainties. Announcing the third bi-monthly monetary policy of the current fiscal, RBI Governor Sanjay Malhotra said the growth rate projection for FY26 has been retained at 6.5%. Meanwhile, Brent crude prices rose 0.52% to $67.24 per barrel in futures trade. The dollar index, which gauges the greenback's strength against a basket of six currencies, fell 0.10% to 98.08. In the domestic equity market, the Sensex advanced 79.27 points to settle at 80,623.26, while Nifty was up 21.95 points to 24,596.15. Foreign institutional investors (FIIs) offloaded equities worth ₹4,999.10 crore on a net basis on Wednesday(August 6, 2025), according to exchange data.
